Anti-CD19 chimeric antigen receptor T cells secreting anti-PD-L1 single-chain variable fragment attenuate PD-L1 mediated T cell inhibition - ScienceDirect
Cancers | Free Full-Text | Combination of High-Resolution Structures for the B Cell Receptor and Co-Receptors Provides an Understanding of Their Interactions with Therapeutic Antibodies
Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains | Nature Biomedical Engineering
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
of CD19 and CD20 expression during B cell development. CD19 expression... | Download Scientific Diagram
Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
CD19 Monoclonal Antibody (6OMP31) (14-0194-82)
Generation and characterization of CD19-iCre mice as a tool for efficient and specific conditional gene targeting in B cells | Scientific Reports
CD19(high) and CD19(low) subpopulations of B cells. Fresh PBMCs from... | Download Scientific Diagram
Regulation of CD19 CAR-T cell activation based on an engineered downstream transcription factor: Molecular Therapy - Oncolytics
Flow Cytometry of Hematological Malignancies: 9781119611257: Medicine & Health Science Books @ Amazon.com
Phospho-CD19 (Tyr531) Antibody | Cell Signaling Technology
Frontiers | Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies
CD19/BAFF-R dual-targeted CAR T cells for the treatment of mixed antigen-negative variants of acute lymphoblastic leukemia | Leukemia
Resources for CD 19 | Biomarker for normal and neplastic B cell | OriGene
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications
Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells
CAR.CD19 T-cells generated from Bcp-ALL patients' derived PBMCs... | Download Scientific Diagram
Anti-human CD3/CD19 bispecific antibody | InvivoGen
CD19 - an overview | ScienceDirect Topics
Frontiers | Failure of ALL recognition by CAR T cells: a review of CD 19-negative relapses after anti-CD 19 CAR-T treatment in B-ALL
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - ScienceDirect
Cells | Free Full-Text | Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial | Nature Medicine
